BACKGROUND: Lynch syndrome (LS) is associated with a high risk for colorectal cancer (CRC) and extracolonic malignancies, such as endometrial carcinoma (EC). The risk is dependent of the affected mismatch repair gene. The aim of the present study was to calculate the cumulative risk of LS related cancers in proven MLH1, MSH2 and MSH6 mutation carriers. METHODS: The studypopulation consisted out of 67 proven LS families. Clinical information including mutation status and tumour diagnosis was collected. Cumulative risks were calculated and compared using Kaplan Meier survival analysis. RESULTS: MSH6 mutation carriers, both males and females had the lowest risk for developing CRC at age 70 years, 54% and 30% respectively and the age of onset was delayed by 3-5 years in males. With respect to endometrial carcinoma, female MSH6 mutation carriers had the highest risk at age 70 years (61%) compared to MLH1 (25%) and MSH2 (49%). Also, the age of EC onset was delayed by 5-10 years in comparison with MLH1 and MSH2. CONCLUSIONS: Although the cumulative lifetime risk of LS related cancer is similar, MLH1, MSH2 and MSH6 mutations seem to cause distinguishable cancer risk profiles. Female MSH6 mutation carriers have a lower CRC risk and a higher risk for developing endometrial carcinoma. As a consequence, surveillance colonoscopy starting at age 30 years instead of 20-25 years is more suitable. Also, prophylactic hysterectomy may be more indicated in female MSH6 mutation carriers compared to MLH1 and MSH2 mutation carriers.
BACKGROUND:Lynch syndrome (LS) is associated with a high risk for colorectal cancer (CRC) and extracolonic malignancies, such as endometrial carcinoma (EC). The risk is dependent of the affected mismatch repair gene. The aim of the present study was to calculate the cumulative risk of LS related cancers in proven MLH1, MSH2 and MSH6 mutation carriers. METHODS: The studypopulation consisted out of 67 proven LS families. Clinical information including mutation status and tumour diagnosis was collected. Cumulative risks were calculated and compared using Kaplan Meier survival analysis. RESULTS:MSH6 mutation carriers, both males and females had the lowest risk for developing CRC at age 70 years, 54% and 30% respectively and the age of onset was delayed by 3-5 years in males. With respect to endometrial carcinoma, female MSH6 mutation carriers had the highest risk at age 70 years (61%) compared to MLH1 (25%) and MSH2 (49%). Also, the age of EC onset was delayed by 5-10 years in comparison with MLH1 and MSH2. CONCLUSIONS: Although the cumulative lifetime risk of LS related cancer is similar, MLH1, MSH2 and MSH6 mutations seem to cause distinguishable cancer risk profiles. Female MSH6 mutation carriers have a lower CRC risk and a higher risk for developing endometrial carcinoma. As a consequence, surveillance colonoscopy starting at age 30 years instead of 20-25 years is more suitable. Also, prophylactic hysterectomy may be more indicated in female MSH6 mutation carriers compared to MLH1 and MSH2 mutation carriers.
Authors: Heather Hampel; Julie A Stephens; Eero Pukkala; Risto Sankila; Lauri A Aaltonen; Jukka-Pekka Mecklin; Albert de la Chapelle Journal: Gastroenterology Date: 2005-08 Impact factor: 22.682
Authors: Kathleen M Schmeler; Henry T Lynch; Lee-may Chen; Mark F Munsell; Pamela T Soliman; Mary Beth Clark; Molly S Daniels; Kristin G White; Stephanie G Boyd-Rogers; Peggy G Conrad; Kathleen Y Yang; Mary M Rubin; Charlotte C Sun; Brian M Slomovitz; David M Gershenson; Karen H Lu Journal: N Engl J Med Date: 2006-01-19 Impact factor: 91.245
Authors: Laura Renkonen-Sinisalo; Ralf Bützow; Arto Leminen; Pentti Lehtovirta; Jukka-Pekka Mecklin; Heikki J Järvinen Journal: Int J Cancer Date: 2007-02-15 Impact factor: 7.396
Authors: Andrea E de Jong; Yvonne M C Hendriks; Jan H Kleibeuker; Sybrand Y de Boer; Annemieke Cats; Gerrit Griffioen; Fokko M Nagengast; Frits G Nelis; Matti A Rookus; Hans F A Vasen Journal: Gastroenterology Date: 2006-03 Impact factor: 22.682
Authors: D Ramsoekh; M E van Leerdam; C M J Tops; D Dooijes; E W Steyerberg; E J Kuipers; A Wagner Journal: Clin Genet Date: 2007-10-07 Impact factor: 4.438
Authors: Yvonne M C Hendriks; Shantie Jagmohan-Changur; Heleen M van der Klift; Hans Morreau; Marjo van Puijenbroek; Carli Tops; Theo van Os; Anja Wagner; Margreet G F M Ausems; Encarna Gomez; Martijn H Breuning; Annette H J T Bröcker-Vriends; Hans F A Vasen; Juul Th Wijnen Journal: Gastroenterology Date: 2006-02 Impact factor: 22.682
Authors: H F A Vasen; G Möslein; A Alonso; I Bernstein; L Bertario; I Blanco; J Burn; G Capella; C Engel; I Frayling; W Friedl; F J Hes; S Hodgson; J-P Mecklin; P Møller; F Nagengast; Y Parc; L Renkonen-Sinisalo; J R Sampson; A Stormorken; J Wijnen Journal: J Med Genet Date: 2007-02-27 Impact factor: 6.318
Authors: Bente A Talseth-Palmer; Mary McPhillips; Claire Groombridge; Allan Spigelman; Rodney J Scott Journal: Hered Cancer Clin Pract Date: 2010-05-21 Impact factor: 2.857
Authors: Yi Yang; Raghothama Chaerkady; Kumaran Kandasamy; Tai-Chung Huang; Lakshmi Dhevi N Selvan; Sutopa B Dwivedi; Oliver A Kent; Joshua T Mendell; Akhilesh Pandey Journal: Mol Biosyst Date: 2010-06-14
Authors: J F Haanstra; H F A Vasen; S Sanduleanu; E J van der Wouden; J J Koornstra; J H Kleibeuker; W H de Vos Tot Nederveen Cappel Journal: Int J Colorectal Dis Date: 2013-07-16 Impact factor: 2.571
Authors: Marlies J E Kempers; Roland P Kuiper; Charlotte W Ockeloen; Pierre O Chappuis; Pierre Hutter; Nils Rahner; Hans K Schackert; Verena Steinke; Elke Holinski-Feder; Monika Morak; Matthias Kloor; Reinhard Büttner; Eugene T P Verwiel; J Han van Krieken; Iris D Nagtegaal; Monique Goossens; Rachel S van der Post; Renée C Niessen; Rolf H Sijmons; Irma Kluijt; Frans B L Hogervorst; Edward M Leter; Johan J P Gille; Cora M Aalfs; Egbert J W Redeker; Frederik J Hes; Carli M J Tops; Bernadette P M van Nesselrooij; Marielle E van Gijn; Encarna B Gómez García; Diana M Eccles; David J Bunyan; Sapna Syngal; Elena M Stoffel; Julie O Culver; Melanie R Palomares; Tracy Graham; Lea Velsher; Janos Papp; Edith Oláh; Tsun L Chan; Suet Y Leung; Ad Geurts van Kessel; Lambertus A L M Kiemeney; Nicoline Hoogerbrugge; Marjolijn J L Ligtenberg Journal: Lancet Oncol Date: 2010-12-08 Impact factor: 41.316
Authors: Mohammad R Akbari; Shiyu Zhang; Deborah Cragun; Ji-Hyun Lee; Domenico Coppola; John McLaughlin; Harvey A Risch; Barry Rosen; Patricia Shaw; Thomas A Sellers; Joellen Schildkraut; Steven A Narod; Tuya Pal Journal: Fam Cancer Date: 2017-07 Impact factor: 2.375